V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310007317 | 310004465 | 1.77 | 80.8 | Disease modification (D) | null | 2017-05-20 | GEM-P | null | null | 310017575 | GEMCITABINE + PACLITAXEL |
| 310007318 | 310004465 | 1.6 | 65.4 | Palliative (P) | 2018-02-14 | 2018-02-28 | PEMBROLIZUMAB | N | N | 310017575 | PEMBROLIZUMAB |
| 310007319 | 310007881 | 1.59 | 57.8 | Palliative (P) | 2015-03-02 | 2015-03-13 | Brentuximab | N | N | 310017591 | BRENTUXIMAB |
| 310007320 | 310004467 | 1.57 | 55.5 | Not known (9) | 2017-04-05 | 2017-05-31 | BEAM | N | N | 310017593 | BEAM |
| 310007321 | 310004468 | 1.52 | 61 | Curative (C) | 2017-05-12 | 2017-05-19 | Mini BEAM | 02 | N | 310017595 | BEAM |
| 310007322 | 310007882 | 1.65 | 68 | Palliative (P) | 2014-08-22 | 2014-09-04 | CISPLATIN + GEMCITABINE | N | N | 310017601 | CISPLATIN + GEMCITABINE |
| 310007323 | 310007882 | 1.78 | 87 | Palliative (P) | 2018-05-08 | 2018-05-08 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 310017601 | GEMCITABINE |
| 310007324 | 310004469 | 1.55 | 68.2 | Palliative (P) | null | 2018-12-04 | Carboplatin + Liposomal Doxorubicin | N | null | 310017616 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007325 | 310007883 | 1.77 | 79.95 | Palliative (P) | null | 2016-12-13 | PEMBROLIZUMAB | 02 | null | 310017616 | PEMBROLIZUMAB |
| 310007326 | 310004470 | 1.55 | 73.1 | null | 2018-10-03 | 2018-11-04 | Carboplatin + Liposomal Doxorubicin | N | N | 310017629 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007327 | 310004471 | 1.55 | 79.4 | Palliative (P) | 2014-07-02 | 2014-07-13 | Ipilimumab | 2 | null | 310017633 | IPILIMUMAB |
| 310007328 | 310004472 | 1.77 | null | Disease modification (D) | 2017-11-07 | 2017-11-11 | Ipilimumab | 02 | N | 310017634 | IPILIMUMAB |
| 310007329 | 310004473 | 1.7 | 121 | Curative (C) | 2019-04-17 | 2019-04-17 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 310017644 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007330 | 310004476 | 1.63 | 55.1 | null | 2015-10-26 | 2015-11-26 | Cisplatin | 02 | N | 310017645 | CISPLATIN |
| 310007331 | 310004476 | 1.7 | null | null | 2016-09-11 | 2016-09-17 | Cyclophosphamide High Dose | 02 | N | 310017645 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310007332 | 310007888 | 1.51 | 76 | Curative (C) | 2014-02-24 | 2014-07-20 | CARBOPLATIN + ETOPOSIDE | N | N | 310017651 | ESHAP |
| 310007333 | 310007888 | 1.73 | null | Palliative (P) | 2013-09-20 | 2013-09-26 | Etoposide oral | N | N | 310017651 | ETOPOSIDE |
| 310007334 | 310011239 | 1.58 | 96 | Disease modification (D) | 2018-09-30 | 2018-10-18 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 310017676 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310007335 | 310004478 | 1.68 | 51 | Palliative (P) | 2014-12-30 | 2015-01-06 | Cisplatin + Radiotherapy | 2 | N | 310017682 | CISPLATIN + RT |
| 310007336 | 310007889 | 1.52 | 67 | Curative (C) | 2014-06-01 | 2014-06-02 | Cisplatin | 2 | N | 310017682 | CISPLATIN |
| 310007338 | 310004480 | 1.7 | 59.3 | Curative (C) | 2019-04-06 | 2019-04-07 | GDP | N | N | 310017711 | GDP |
| 310007339 | 310004481 | 1.73 | 71.8 | Palliative (P) | 2017-06-20 | 2017-06-24 | Rituximab | 2 | N | 310017721 | RITUXIMAB |
| 310007340 | 310004485 | 1.49 | null | null | 2016-07-04 | 2016-08-14 | Cisplatin | N | N | 310017725 | CISPLATIN |
| 310007341 | 310004486 | 1.77 | 20.2 | Curative (C) | 2014-09-24 | 2014-10-01 | Methotrexate intrathecal | Y | N | 310017726 | METHOTREXATE INTRATHECAL |
| 310007343 | 310004489 | 1.73 | null | Curative (C) | 2018-11-07 | 2019-01-02 | Methotrexate intrathecal | N | N | 310017733 | METHOTREXATE INTRATHECAL |
| 310007344 | 310004490 | 1.6 | 55.8 | Disease modification (D) | 2016-05-10 | 2016-05-14 | Etoposide oral | 02 | null | 310017735 | ETOPOSIDE |
| 310007345 | 310007895 | 1.55 | 23.4 | Curative (C) | 2017-07-29 | 2017-09-21 | Bexarotene | null | N | 310017744 | BEXAROTENE |
| 310007346 | 310004492 | 1.69 | null | Curative (C) | 2016-06-26 | 2016-06-26 | Etoposide oral | N | N | 310017745 | ETOPOSIDE |
| 310007347 | 310007896 | 1.8 | 103.9 | null | 2018-05-06 | 2018-05-14 | Cyclophosphamide oral | N | N | 310017746 | CYCLOPHOSPHAMIDE |
| 310007348 | 310007896 | 1.74 | 61.55 | null | 2017-07-17 | 2017-11-12 | Docetaxel + Gemcitabine with GCSF | N | N | 310017746 | DOCETAXEL + GEMCITABINE |
| 310007349 | 310004493 | 1.6 | 77.5 | Adjuvant (A) | 2015-05-21 | 2015-08-13 | CARBOPLATIN + ETOPOSIDE | N | N | 310017775 | BEXAROTENE |
| 310007350 | 310004494 | null | 71.3 | Curative (C) | null | 2016-09-10 | Cisplatin | N | null | 310017778 | CISPLATIN |
| 310007351 | 310004495 | null | 60.2 | Adjuvant (A) | 2016-10-10 | 2016-10-11 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310017787 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007352 | 310004495 | 1.7 | null | Curative (C) | 2013-10-16 | 2013-11-07 | CYCLOPHOSPHAMIDE | 02 | N | 310017787 | CYCLOPHOSPHAMIDE |
| 310007353 | 310004495 | 1.74 | 96.8 | Adjuvant (A) | 2015-01-27 | 2015-01-28 | Cisplatin 100 + RT(H&N) 1 day | N | N | 310017787 | CISPLATIN + RT |
| 310007354 | 310010684 | 1.57 | null | Curative (C) | 2017-11-19 | 2017-11-23 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310017795 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007355 | 310010684 | 1.62 | 55 | Palliative (P) | 2017-12-08 | 2017-12-11 | Docetaxel 75mg/m2 (21 day) | 2 | Y | 310017795 | DOCETAXEL |
| 310007356 | 310004496 | 1.71 | 104 | null | 2013-11-03 | 2013-11-03 | Etoposide oral | null | N | 310017800 | ETOPOSIDE |
| 310007357 | 310004496 | 1.82 | 85.3 | Palliative (P) | 2014-05-19 | 2014-05-21 | Docetaxel | 99 | N | 310017800 | DOCETAXEL |
| 310007358 | 310004497 | null | 81.8 | Curative (C) | 2017-02-27 | 2017-07-16 | CYCLOPHOSPHAMIDE + FILGRASTIM | N | N | 310017802 | CYCLOPHOSPHAMIDE |
| 310007359 | 310007900 | 1.74 | 70.4 | Curative (C) | 2014-11-23 | 2014-11-24 | Cisplatin 100 + RT(H&N) 1 day | N | null | 310017805 | CISPLATIN + RT |
| 310007360 | 310004498 | 1.82 | 85.3 | Neo-adjuvant (N) | 2014-06-25 | 2014-07-02 | Carboplatin + Etoposide iv&po | N | N | 310017812 | UKALL2011 |
| 310007361 | 310007901 | 1.74 | 91.7 | null | 2018-01-17 | 2018-04-30 | GDP | N | N | 310017816 | GDP |
| 310007362 | 310004499 | 1.82 | 114 | Curative (C) | 2013-04-18 | 2013-04-24 | CHOP R - 21 days | Y | N | 310017816 | CHOP R |
| 310007363 | 310007903 | 1.78 | 83.9 | Curative (C) | null | 2015-06-08 | Docetaxel 75mg/m2 (21 day) | N | N | 310017832 | DOCETAXEL |
| 310007364 | 310007903 | 1.72 | 83.4 | Palliative (P) | 2016-08-07 | 2016-08-08 | Rituximab | N | null | 310017832 | RITUXIMAB |
| 310007366 | 310004502 | 1.73 | 113.4 | Disease modification (D) | 2016-06-23 | 2016-11-09 | Cyclophosphamide oral | N | N | 310017853 | CYCLOPHOSPHAMIDE |
| 310007367 | 310007904 | 1.73 | 66.3 | Curative (C) | 2017-02-24 | 2017-03-29 | Cyclophosphamide oral | 2 | null | 310017855 | CYCLOPHOSPHAMIDE |
| 310007368 | 310007904 | 1.56 | 50.3 | Palliative (P) | null | 2017-03-19 | CHOP R - 21 days | Y | null | 310017855 | CHOP R |
| 310007369 | 310007904 | 1.7 | 90.3 | null | 2015-08-23 | 2015-08-31 | Ipilimumab | N | Y | 310017855 | IPILIMUMAB |